Jingshan Tong

1.8k total citations
32 papers, 1.3k citations indexed

About

Jingshan Tong is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Jingshan Tong has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 11 papers in Cell Biology and 9 papers in Oncology. Recurrent topics in Jingshan Tong's work include Microtubule and mitosis dynamics (9 papers), Ubiquitin and proteasome pathways (7 papers) and Cancer-related Molecular Pathways (7 papers). Jingshan Tong is often cited by papers focused on Microtubule and mitosis dynamics (9 papers), Ubiquitin and proteasome pathways (7 papers) and Cancer-related Molecular Pathways (7 papers). Jingshan Tong collaborates with scholars based in United States, China and Brazil. Jingshan Tong's co-authors include Lin Zhang, Jian Yu, Fangdong Zou, Shuai Tan, Dongshi Chen, Qing‐Yuan Sun, Zaneta Nikolovska‐Coleska, Yiping Hou, Jun Sheng and Shu‐Tao Qi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Jingshan Tong

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingshan Tong United States 20 906 410 238 174 171 32 1.3k
Lubing Gu United States 24 1.2k 1.3× 701 1.7× 313 1.3× 81 0.5× 171 1.0× 39 1.6k
HP Koeffler United States 18 975 1.1× 534 1.3× 178 0.7× 77 0.4× 232 1.4× 41 1.5k
Frédèrique Verdier France 20 771 0.9× 504 1.2× 142 0.6× 100 0.6× 330 1.9× 36 1.6k
Audrey Sirvent France 20 808 0.9× 939 2.3× 148 0.6× 155 0.9× 152 0.9× 32 1.8k
Zhongping Cheng China 19 600 0.7× 175 0.4× 308 1.3× 78 0.4× 240 1.4× 72 1.2k
Muxiang Zhou United States 26 1.6k 1.8× 893 2.2× 525 2.2× 113 0.6× 355 2.1× 51 2.3k
Xiao Qi Wang Hong Kong 22 1.1k 1.2× 629 1.5× 394 1.7× 115 0.7× 103 0.6× 33 1.5k
Huan Yan China 21 763 0.8× 209 0.5× 302 1.3× 435 2.5× 176 1.0× 38 1.3k
Yongxin Zou China 21 1.2k 1.3× 269 0.7× 363 1.5× 81 0.5× 184 1.1× 54 1.5k
Karolina Wojtowicz Poland 16 572 0.6× 445 1.1× 246 1.0× 80 0.5× 116 0.7× 25 930

Countries citing papers authored by Jingshan Tong

Since Specialization
Citations

This map shows the geographic impact of Jingshan Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingshan Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingshan Tong more than expected).

Fields of papers citing papers by Jingshan Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingshan Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingshan Tong. The network helps show where Jingshan Tong may publish in the future.

Co-authorship network of co-authors of Jingshan Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Jingshan Tong. A scholar is included among the top collaborators of Jingshan Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingshan Tong. Jingshan Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fletcher, Rochelle, Jingshan Tong, Brian J. Leibowitz, et al.. (2021). Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis. Oncogene. 40(11). 2035–2050. 25 indexed citations
2.
Tong, Jingshan, Xiao Tan, Man Gao, et al.. (2021). BET protein degradation triggers DR5-mediated immunogenic cell death to suppress colorectal cancer and potentiate immune checkpoint blockade. Oncogene. 40(48). 6566–6578. 18 indexed citations
3.
Song, Xiangping, Lin Shen, Jingshan Tong, et al.. (2020). Mcl-1 inhibition overcomes intrinsic and acquired Regorafenib resistance in Colorectal Cancer. Theranostics. 10(18). 8098–8110. 53 indexed citations
4.
Tan, Xiao, Jingshan Tong, Yi‐Jun Wang, et al.. (2019). BET Inhibitors Potentiate Chemotherapy and Killing of SPOP -Mutant Colon Cancer Cells via Induction of DR5. Cancer Research. 79(6). 1191–1203. 45 indexed citations
5.
Chen, Dongshi, Jingshan Tong, Liheng Yang, et al.. (2018). PUMA amplifies necroptosis signaling by activating cytosolic DNA sensors. Proceedings of the National Academy of Sciences. 115(15). 3930–3935. 143 indexed citations
6.
Tong, Jingshan, Xingnan Zheng, Xiao Tan, et al.. (2018). Mcl-1 Phosphorylation without Degradation Mediates Sensitivity to HDAC Inhibitors by Liberating BH3-Only Proteins. Cancer Research. 78(16). 4704–4715. 41 indexed citations
7.
Tong, Jingshan, Dongshi Chen, Sandra Misale, et al.. (2018). Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer. Oncogene. 37(33). 4599–4610. 24 indexed citations
8.
Tong, Jingshan, Shuai Tan, Zaneta Nikolovska‐Coleska, et al.. (2017). FBW7 -Dependent Mcl-1 Degradation Mediates the Anticancer Effect of Hsp90 Inhibitors. Molecular Cancer Therapeutics. 16(9). 1979–1988. 43 indexed citations
9.
Tong, Jingshan, Peng Wang, Shuai Tan, et al.. (2017). Mcl-1 Degradation Is Required for Targeted Therapeutics to Eradicate Colon Cancer Cells. Cancer Research. 77(9). 2512–2521. 104 indexed citations
10.
Tong, Jingshan, Shuai Tan, Fangdong Zou, Jian Yu, & Lin Zhang. (2016). FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation. Oncogene. 36(6). 787–796. 121 indexed citations
11.
Misale, Sandra, Ivana Božić, Jingshan Tong, et al.. (2015). Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers. Nature Communications. 6(1). 8305–8305. 91 indexed citations
12.
Han, Bo, Weilong Yao, You-Take Oh, et al.. (2015). The novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5. Oncotarget. 6(19). 17532–17542. 37 indexed citations
13.
Tong, Jingshan, et al.. (2013). Targeting Bax interaction sites reveals that only homo-oligomerization sites are essential for its activation. Cell Death and Differentiation. 20(5). 744–754. 30 indexed citations
14.
Tong, Jingshan, Qinghua Zhang, Xin Huang, et al.. (2011). Icaritin Causes Sustained ERK1/2 Activation and Induces Apoptosis in Human Endometrial Cancer Cells. PLoS ONE. 6(3). e16781–e16781. 124 indexed citations
15.
Huang, Xin, Jingshan Tong, Zhen‐Bo Wang, et al.. (2011). JNK2 Participates in Spindle Assembly during Mouse Oocyte Meiotic Maturation. Microscopy and Microanalysis. 17(2). 197–205. 19 indexed citations
16.
Wang, Zhen‐Bo, Xiang‐Hong Ou, Jingshan Tong, et al.. (2010). The SUMO pathway functions in mouse oocyte maturation. Cell Cycle. 9(13). 2640–2646. 41 indexed citations
17.
Yang, Cairong, De‐Qiang Miao, Qinghua Zhang, et al.. (2010). Short-term Preservation of Porcine Oocytes in Ambient Temperature: Novel Approaches. PLoS ONE. 5(12). e14242–e14242. 19 indexed citations
18.
Zhang, Qing-Hua, Wei Liang, Jingshan Tong, et al.. (2010). Localization and function of mSpindly during mouse oocyte meiotic maturation. Cell Cycle. 9(11). 2230–2236. 13 indexed citations
19.
Yuan, Ju, Baozeng Xu, Shu‐Tao Qi, et al.. (2010). MAPK-Activated Protein Kinase 2 Is Required for Mouse Meiotic Spindle Assembly and Kinetochore-Microtubule Attachment. PLoS ONE. 5(6). e11247–e11247. 17 indexed citations
20.
Tong, Jingshan, Zhen‐Bo Wang, Sen Li, et al.. (2010). ER-α36, a Novel Variant of ER-α, Mediates Estrogen-Stimulated Proliferation of Endometrial Carcinoma Cells via the PKCδ/ERK Pathway. PLoS ONE. 5(11). e15408–e15408. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lubing Gu Breakdown of academic impact, for papers by HP Koeffler Breakdown of academic impact, for papers by Frédèrique Verdier Breakdown of academic impact, for papers by Audrey Sirvent Breakdown of academic impact, for papers by Zhongping Cheng Breakdown of academic impact, for papers by Muxiang Zhou Breakdown of academic impact, for papers by Xiao Qi Wang Breakdown of academic impact, for papers by Huan Yan Breakdown of academic impact, for papers by Yongxin Zou Breakdown of academic impact, for papers by Karolina Wojtowicz
Rankless by CCL
2026